FDA Inspection 1207367 — Raymond E. Easley, D.O.

Raymond E. Easley, D.O. — FEI 3026057412

The FDA completed an inspection of Raymond E. Easley, D.O. on May 26, 2023 in Snellville, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 26, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Snellville, GA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
737821 CFR 50.27(a)Copy of consent form not provided
756021 CFR 312.60FD-1572, protocol compliance